Electrochemical detection of BRAF V600E mutation in a liquid biopsy format: LAMPing the way to an improved diagnostics and treatment

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209805%3A_____%2F25%3A00080061" target="_blank" >RIV/00209805:_____/25:00080061 - isvavai.cz</a>

Výsledek na webu

<a href="https://advanced.onlinelibrary.wiley.com/doi/full/10.1002/admt.202401404" target="_blank" >https://advanced.onlinelibrary.wiley.com/doi/full/10.1002/admt.202401404</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1002/admt.202401404" target="_blank" >10.1002/admt.202401404</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Electrochemical detection of BRAF V600E mutation in a liquid biopsy format: LAMPing the way to an improved diagnostics and treatment

Popis výsledku v původním jazyce

The BRAF V600E substitution, predominantly found in melanoma and metastatic colorectal cancer (mCRC), is associated with aggressive traits and poor prognosis. Molecular testing of the BRAF mutational status is crucial for guiding therapeutic decisions, driving the necessity for new rapid diagnostic technologies. Here, a novel LAMP-based assay is presented for fast and selective amplification of mutated DNA, coupled with simple electrochemical detection on electrode biochips. The assay demonstrated high selectivity across cell lines and in 51 cancer patients, detecting mutations in both tumor tissue DNA and circulating tumor DNA (ctDNA) in serum. Clear discrimination between the mutated and wild-type sequences is achieved, in perfect agreement with either NGS or ddPCR. The bioassay offers a simple and efficient alternative to traditional PCR methods for point-of-care diagnostics, particularly in settings with limited equipment and resources.

Název v anglickém jazyce

Electrochemical detection of BRAF V600E mutation in a liquid biopsy format: LAMPing the way to an improved diagnostics and treatment

Popis výsledku anglicky

The BRAF V600E substitution, predominantly found in melanoma and metastatic colorectal cancer (mCRC), is associated with aggressive traits and poor prognosis. Molecular testing of the BRAF mutational status is crucial for guiding therapeutic decisions, driving the necessity for new rapid diagnostic technologies. Here, a novel LAMP-based assay is presented for fast and selective amplification of mutated DNA, coupled with simple electrochemical detection on electrode biochips. The assay demonstrated high selectivity across cell lines and in 51 cancer patients, detecting mutations in both tumor tissue DNA and circulating tumor DNA (ctDNA) in serum. Clear discrimination between the mutated and wild-type sequences is achieved, in perfect agreement with either NGS or ddPCR. The bioassay offers a simple and efficient alternative to traditional PCR methods for point-of-care diagnostics, particularly in settings with limited equipment and resources.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

10405 - Electrochemistry (dry cells, batteries, fuel cells, corrosion metals, electrolysis)

Projekt

Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2025

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Advanced Materials Technologies

ISSN

—

e-ISSN

2365-709X

Svazek periodika

10

Číslo periodika v rámci svazku

7

Stát vydavatele periodika

DE - Spolková republika Německo

Počet stran výsledku

11

Strana od-do

2401404

Kód UT WoS článku

001368354700001

EID výsledku v databázi Scopus

2-s2.0-85211122040